![]() |
市场调查报告书
商品编码
1954618
毛细管电泳市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2026-2034)Capillary Electrophoresis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球毛细管电泳 (CE) 市场规模为 4.3875 亿美元,预计 2026 年将成长至 4.613 亿美元,到 2034 年将达到 6.7337 亿美元。这意味着在预测期内,复合年增长率 (CAGR) 为 4.84%。北美地区在 2025 年以 38.05% 的市场占有率(1.6694 亿美元)领先市场,这主要得益于该地区活跃的研发活动和先进的临床基础设施。
毛细管电泳是一种分析技术,它利用高压电场,根据离子和分子的大小和电荷,在毛细管中分离它们。其应用包括核酸分析、蛋白质表征和临床诊断。市场成长的驱动因素包括製药和生技公司研发活动的增加,以及精准医疗的日益普及。
市场动态
驱动因素
癌症和遗传性疾病等慢性疾病的日益普遍,以及对精准医疗需求的增长,正在推动市场成长。毛细管电泳具有高解析度和高速的分析能力,这对于疾病诊断和个人化医疗至关重要。 2025年1月,美国癌症协会报告称,美国约有1,860万人患有癌症,预计到2035年,这一数字将超过2,200万。患者数量的增加正在推动临床实验室采用毛细管电泳技术。
限制因子
高昂的初始投资和营运成本是市场扩张的障碍。先进的毛细管电泳 (CE) 系统的价格从 2 万美元到 15 万美元不等,此外还需要支付耗材和维护等营运成本,这限制了小型实验室和新兴市场的采用。
机会
新兴市场和学术研究蕴藏着巨大的成长机会。亚太地区、拉丁美洲和非洲各国政府正在加大对製药和生物技术研发的投入,从而创造了对经济高效的 CE 系统的需求。桌上型和小型 CE 设备是实验室入门的理想选择,有助于这些地区的扩张。学术机构越来越多地将 CE 用于教育和研究,进一步提升了市场的潜力。
挑战
熟练专业人员的短缺是一项重大挑战。操作 CE 设备需要具备样品製备、故障排除和数据分析的技术专长。 2023年2月, "科学与技术研究杂誌" (Journal of Scientific & Technical Research)报道称,美国约有25,000名医疗技术人员缺口,这限制了先进毛细管电泳系统的有效应用,并减缓了市场增长,尤其是在发展中国家。
市场趋势
毛细管电泳-质谱联用(CE-MS)是主要的市场趋势。 CE-MS能够增强对生物分子、代谢物和胜肽的定性和定量分析,这些分析对于蛋白质体学、代谢组学和药物发现至关重要。 2024年6月,CMP Scientific发布了BioSummit CVA系统,这是一款用于高精度蛋白质分析的新一代CE-MS平台,反映了生物製药研究和临床诊断领域对CE-MS日益增长的需求。
依产品划分:市场分为仪器、耗材及软体。 预计到2026年,耗材细分市场将占最大占有率,达到58.53%,这主要得益于学术界、製药界和生物技术实验室对毛细管、缓衝液、试剂和试剂盒的持续更换需求。包括自动化和半自动化CE系统在内的仪器预计将以5.0%的复合年增长率成长。
依模式划分:此细分市场包括毛细管区带电泳、毛细管凝胶电泳(CGE)及毛细管电层析。 2025年,毛细管电泳(CGE)引领市场,预计2026年将占43.97%的市占率。这主要得益于其在核酸和蛋白质分析领域的应用。毛细管电色谱预计将以5.4%的复合年增长率(CAGR)成长。
依应用领域划分:此细分市场包括核酸分析、药物研发、蛋白质和胜肽分析以及临床诊断。核酸分析在2025年占最大市场占有率,预计2026年将维持30.4%的市占率。这主要得益于DNA/RNA定序和基因分型分析的快速发展。蛋白质和胜肽分析预计将以5.8%的复合年增长率(CAGR)增长。
终端使用者包括学术和研究机构、製药和生物技术公司、临床实验室等。学术和研究机构在2025年占最大占有率,预计2026年将维持41.36%的占有率。这要归功于诸如密西根州立大学2024年Sun Lab CE-MS暑期学校等培训计画。製药和生物技术公司预计将以5.3%的复合年增长率成长。
The global capillary electrophoresis (CE) market was valued at USD 438.75 million in 2025 and is projected to grow to USD 461.3 million in 2026, reaching USD 673.37 million by 2034, reflecting a CAGR of 4.84% during the forecast period. North America dominated the market in 2025 with a 38.05% share, amounting to USD 166.94 million, due to the region's strong research and development (R&D) activities and advanced clinical infrastructure.
Capillary electrophoresis is an analytical technique that separates ions and molecules based on size and charge in a capillary tube using a high-voltage electric field. Its applications include nucleic acid analysis, protein characterization, and clinical diagnostics. The market growth is fueled by increasing R&D initiatives by pharmaceutical and biotechnology companies and rising adoption of precision medicine.
Market Dynamics
Drivers
The increasing prevalence of chronic diseases such as cancer and genetic disorders, combined with the rising demand for precision medicine, is driving market growth. CE offers high-resolution, fast analytical capabilities, critical for disease diagnostics and personalized treatments. In January 2025, the American Cancer Society reported that approximately 18.6 million individuals in the U.S. were living with a history of cancer, a number expected to surpass 22 million by 2035. This rising patient population fuels CE adoption in clinical laboratories.
Restraints
High initial investment and running costs are limiting market expansion. Advanced CE systems range between USD 20,000 and USD 150,000, with additional operational costs for consumables and maintenance, restricting adoption in smaller labs and emerging markets.
Opportunities
Emerging markets and academic research present significant growth opportunities. Governments in Asia Pacific, Latin America, and Africa are investing in pharmaceutical and biotech R&D, creating demand for cost-efficient CE systems. Benchtop and compact CE instruments provide affordable entry points for laboratories, supporting expansion in these regions. Academic institutions are increasingly adopting CE for education and research, further boosting market potential.
Challenges
A shortage of skilled professionals is a key challenge. Operating CE instruments requires technical expertise in sample preparation, troubleshooting, and data analysis. In February 2023, the Journal of Scientific & Technical Research reported a shortage of approximately 25,000 medical technologists in the U.S., restricting effective utilization of advanced CE systems and slowing market growth, especially in developing countries.
Market Trends
Integration with mass spectrometry (CE-MS) is a key market trend. CE-MS enhances qualitative and quantitative analysis of biomolecules, metabolites, and peptides, critical in proteomics, metabolomics, and drug discovery. In June 2024, CMP Scientific launched the BioSummit CVA system, a next-generation CE-MS platform for high-precision protein analysis, reflecting rising adoption in biopharmaceutical research and clinical diagnostics.
By Product: The market is divided into instruments, consumables, and software. The consumables segment dominated in 2026 with a 58.53% share, driven by ongoing replacement needs for capillaries, buffers, reagents, and cartridges in academic, pharmaceutical, and biotechnology labs. Instruments, including automatic and semi-automatic CE systems, are projected to grow at a CAGR of 5.0%.
By Mode: Segments include capillary zone electrophoresis, capillary gel electrophoresis (CGE), and capillary electrochromatography. CGE led the market in 2025, accounting for a 43.97% share in 2026, primarily due to applications in nucleic acid and protein analysis. Capillary electrochromatography is projected to grow at a CAGR of 5.4%.
By Application: Segments include nucleic acid analysis, drug discovery, protein & peptide analysis, and clinical diagnostics. Nucleic acid analysis held the largest share in 2025, with a 30.4% share in 2026, driven by rapid expansion in DNA/RNA sequencing and genotyping. Protein & peptide analysis is expected to grow at 5.8% CAGR.
By End-user: Segments include academic & research institutes, pharmaceutical & biotechnology companies, clinical labs, and others. Academic & research institutes dominated in 2025, with a 41.36% share in 2026, supported by training initiatives such as the 2024 Sun Lab CE-MS summer school at Michigan State University. Pharmaceutical & biotechnology companies are projected to grow at 5.3% CAGR.
Competitive Landscape
The market is led by Thermo Fisher Scientific, Agilent Technologies, Danaher, Helena Laboratories, QIAGEN, Bio-Rad, Bio-Techne, PerkinElmer, Merck KGaA, and Shimadzu Corporation. Key developments include Thermo Fisher's 2025 launch of the SeqStudio Flex Dx Genetic Analyzer, and Agilent's 2024 ProteoAnalyzer system for protein analysis. Companies focus on product innovation and global expansion to strengthen their market presence.
Conclusion
The global capillary electrophoresis market, valued at USD 438.75 million in 2025, is projected to reach USD 461.3 million in 2026 and USD 673.37 million by 2034, at a CAGR of 4.84%. Growth is driven by rising chronic disease prevalence, adoption of precision medicine, expanding academic research, and integration with mass spectrometry. While high costs and skilled labor shortages pose challenges, opportunities in emerging markets and continuous technological advancements are expected to support sustained market expansion through 2034.
Segmentation By Product, Mode, Application, End-user, and Region
By Product * Instruments
By Mode * Capillary Zone Electrophoresis
By Application * Nucleic Acid Analysis
By End-user * Pharmaceutical & Biotechnology Companies
By Geography * North America (By Product, Mode, Application, End-user, and Country)